Good evening :)
Place Order
Add to Watchlist

Coral Laboratories Ltd

CORALAB

Coral Laboratories Ltd

CORALAB
Health CarePharmaceuticals
SmallcapWith a market cap of ₹137 cr, stock is ranked 2,419
High RiskStock is 4.87x as volatile as Nifty
370.054.03% (-15.55)
370.054.03% (-15.55)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹137 cr, stock is ranked 2,419
High RiskStock is 4.87x as volatile as Nifty
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹137 cr, stock is ranked 2,419
High RiskStock is 4.87x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
15.140.89
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.335.880.57%

Forecast & Ratings

Detailed Forecast 
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

The Company is engaged in the pharmaceutical business. The Company offers products in various categories like sterile, non sterile, nutraceutical and otc products catering to lifestyle segment.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Lower than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of -2.58%, vs industry avg of 8.36%

Decreasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 0.05% to 0.03%

Lower than Industry Net Income

Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of -12.38%, vs industry avg of 9.82%

Loading...

Financial YearFY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023TTM
Total Revenue62.0179.9198.8496.9496.2476.47100.3681.3885.0571.92
Raw Materialssubtract35.6144.5751.3352.5450.7642.9750.1139.0142.1158.38
Power & Fuel Costsubtract1.341.451.841.841.851.822.052.553.10
Employee Costsubtract4.214.886.768.579.849.7010.1811.2311.13
Selling & Administrative Expensessubtract2.614.383.765.016.536.459.329.619.55
Operating & Other expensessubtract3.325.278.839.179.684.229.055.008.43
Depreciation/Amortizationsubtract2.571.731.561.561.902.011.981.992.182.16
Interest & Other Itemssubtract0.150.240.200.200.170.190.040.140.340.02
Taxes & Other Itemssubtract2.645.018.275.605.291.994.062.811.782.26
EPS26.7634.6545.6034.8528.6119.9337.9825.3018.0025.47
DPS2.503.005.002.002.000.000.000.000.000.00
Payout ratio0.090.090.110.060.070.000.000.000.000.00

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Coral Laboratories Ltd21.420.89
Sun Pharmaceutical Industries Ltd45.426.490.72%
Cipla Ltd42.174.980.58%
Dr Reddy's Laboratories Ltd22.334.320.66%

Price Comparison

Compare CORALAB with any stock or ETF
Compare CORALAB with any stock or ETF
CORALAB
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding71.51%0.00%0.00%0.14%28.35%

Mar 2023

Jun 2023

Sep 2023

Dec 2023

Shareholding History

SepDec '22MarJunSepDec '230.14%0.14%0.14%0.14%0.14%0.14%

Insider Trades & Bulk Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateSep 19, 2019

Final
Final | Div/Share: ₹2.00

Dividend/Share

2.00

Ex DateEx Date

Sep 19, 2019

Cash Dividend

Ex DateEx DateSep 18, 2018

Final
Final | Div/Share: ₹2.00

Dividend/Share

2.00

Ex DateEx Date

Sep 18, 2018

Cash Dividend

Ex DateEx DateSep 11, 2017

Final
Final | Div/Share: ₹5.00

Dividend/Share

5.00

Ex DateEx Date

Sep 11, 2017

Cash Dividend

Ex DateEx DateSep 16, 2016

Final
Final | Div/Share: ₹3.00

Dividend/Share

3.00

Ex DateEx Date

Sep 16, 2016

Cash Dividend

Ex DateEx DateSep 8, 2015

Final
Final | Div/Share: ₹2.50

Dividend/Share

2.50

Ex DateEx Date

Sep 8, 2015

News & Opinions

Hmm, looks like data is unavailable here. Please come back after some time.